These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 31188771

  • 41. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J, Rosenberg AE, Bredella MA, Choy E, Hornicek FJ, Nielsen GP, Deshpande V.
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [Abstract] [Full Text] [Related]

  • 42. Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone.
    Puri A, Gulia A, Hegde P, Verma V, Rekhi B.
    Bone Joint J; 2019 Feb; 101-B(2):170-177. PubMed ID: 30700112
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Histomorphometric Analysis of Pre- and Post-Denosumab-Treated Giant Cell Tumor of Bone.
    Ud Din N, Umer M, Park YK.
    Int J Surg Pathol; 2020 Dec; 28(8):859-867. PubMed ID: 32429739
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature.
    Luengo-Alonso G, Mellado-Romero M, Shemesh S, Ramos-Pascua L, Pretell-Mazzini J.
    Arch Orthop Trauma Surg; 2019 Oct; 139(10):1339-1349. PubMed ID: 30877429
    [Abstract] [Full Text] [Related]

  • 48. Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report.
    Park MJ, Ganjoo KN, Ladd AL.
    J Hand Surg Am; 2015 Aug; 40(8):1620-4. PubMed ID: 25935517
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial.
    Ueda T, Morioka H, Nishida Y, Kakunaga S, Tsuchiya H, Matsumoto Y, Asami Y, Inoue T, Yoneda T.
    Ann Oncol; 2015 Oct; 26(10):2149-54. PubMed ID: 26205395
    [Abstract] [Full Text] [Related]

  • 52. Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review.
    Bardakhchyan S, Kager L, Danielyan S, Avagyan A, Karamyan N, Vardevanyan H, Mkhitaryan S, Papyan R, Zohrabyan D, Safaryan L, Sargsyan L, Harutyunyan L, Hakobyan L, Iskanyan S, Tamamyan G.
    Ital J Pediatr; 2017 Mar 29; 43(1):32. PubMed ID: 28356124
    [Abstract] [Full Text] [Related]

  • 53. A case of pelvic giant cell tumor of bone, complete remission with denosumab: long duration of response.
    Bilgetekin I, Mammadkhanli O, Basal FB, Kandemir O, Canbay S, Oksuzoglu B.
    Anticancer Drugs; 2020 Jun 29; 31(5):533-535. PubMed ID: 31743134
    [Abstract] [Full Text] [Related]

  • 54. Immunohistochemical Characterization of Giant Cell Tumor of Bone Treated With Denosumab: Support for Osteoblastic Differentiation.
    Kerr DA, Brcic I, Diaz-Perez JA, Shih A, Wilky BA, Pretell-Mazzini J, Subhawong TK, Nielsen GP, Rosenberg AE.
    Am J Surg Pathol; 2021 Jan 29; 45(1):93-100. PubMed ID: 32773532
    [Abstract] [Full Text] [Related]

  • 55. Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study.
    Urakawa H, Yonemoto T, Matsumoto S, Takagi T, Asanuma K, Watanuki M, Takemoto A, Naka N, Matsumoto Y, Kawai A, Kunisada T, Kubo T, Emori M, Hiraga H, Hatano H, Tsukushi S, Nishida Y, Akisue T, Morii T, Takahashi M, Nagano A, Yoshikawa H, Sato K, Kawano M, Hiraoka K, Tanaka K, Iwamoto Y, Ozaki T.
    World J Surg Oncol; 2018 Aug 08; 16(1):160. PubMed ID: 30089488
    [Abstract] [Full Text] [Related]

  • 56. Giant Cell Tumor of Bone: Review of Current Literature, Evaluation, and Treatment Options.
    Montgomery C, Couch C, Emory CL, Nicholas R.
    J Knee Surg; 2019 Apr 08; 32(4):331-336. PubMed ID: 30449024
    [Abstract] [Full Text] [Related]

  • 57. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
    Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, Jun S, Jacobs I.
    Clin Cancer Res; 2012 Aug 15; 18(16):4415-24. PubMed ID: 22711702
    [Abstract] [Full Text] [Related]

  • 58. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
    Palmerini E, Chawla NS, Ferrari S, Sudan M, Picci P, Marchesi E, Leopardi MP, Syed I, Sankhala KK, Parthasarathy P, Mendanha WE, Pierini M, Paioli A, Chawla SP.
    Eur J Cancer; 2017 May 15; 76():118-124. PubMed ID: 28324746
    [Abstract] [Full Text] [Related]

  • 59. The multidisciplinary management of giant cell tumor of bone.
    Ng VY, Davidson DJ, Kim EY, Pollack SM, Conrad Iii EU, Jones RL.
    Expert Rev Anticancer Ther; 2014 Jul 15; 14(7):783-90. PubMed ID: 24666240
    [Abstract] [Full Text] [Related]

  • 60. Denosumab for the treatment of giant cell tumor of the bone.
    Brodowicz T, Hemetsberger M, Windhager R.
    Future Oncol; 2015 Jul 15; 11(13):1881-94. PubMed ID: 26161925
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.